Status:
COMPLETED
Hospital Based Incidence of Group A Streptococcal Disease in Fiji
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Streptococcus Group A
Eligibility:
All Genders
Brief Summary
The purpose of this ongoing study (Part II) is to estimate the incidence of acute rheumatic fever, rheumatic heart disease, acute post-streptococcal glomerulonephritis (kidney disease), and invasive g...
Detailed Description
This study is a prospective active surveillance study of group A streptococcal (GAS) diseases across two hospital sites designed to estimate the local incidence of acute rheumatic fever (ARF), rheumat...
Eligibility Criteria
Inclusion
- Informed consent will be obtained from all study participants. Children between 0 -17 years of age will be enrolled in the APSGN study. Children between 3-17 years of age and adults between 18-40 years will be enrolled in the ARF study. Children and adults of all ages will be enrolled in the RHD and invasive GAS studies.
Exclusion
- None
Key Trial Info
Start Date :
December 1 2005
Trial Type :
OBSERVATIONAL
End Date :
December 1 2007
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT00264771
Start Date
December 1 2005
End Date
December 1 2007
Last Update
May 2 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Lautoka Hospital
Lautoka, Fiji
2
Colonial War Memorial Hospital
Suva, Fiji